<DOC>
	<DOC>NCT00749632</DOC>
	<brief_summary>The purpose of this study is to determine the safety of three doses of oxybutynin for the treatment of urge urinary incontinence.</brief_summary>
	<brief_title>A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence, Urge</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Females 18 to 75 years of age Has reported symptoms of urge urinary incontinence/overactive bladder Is pregnant or lactating Has had lower urinary tract surgery within 6 months prior to Screening Has a history of urinary retention</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>urinary incontinence, urge</keyword>
	<keyword>urinary urge incontinence</keyword>
	<keyword>urge incontinence</keyword>
	<keyword>over active bladder</keyword>
</DOC>